Status:
RECRUITING
Treating Psychosocial Distress in Glaucoma
Lead Sponsor:
Duke University
Collaborating Sponsors:
National Eye Institute (NEI)
Conditions:
Glaucoma, Primary Open Angle
Distress, Emotional
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
In this study, using three phases, the investigators will use an iterative development approach to refine a behavioral intervention for managing concomitant psychosocial distress in glaucoma. Phase 1:...
Eligibility Criteria
Inclusion
- Inclusion Criteria
- diagnosed with mild, moderate, or severe chronic glaucoma (e.g., POAG),
- had a visual field within the past year at the main Duke Eye Center,
- been prescribed pressure lowering eye drop medication,
- at least mild distress (based on PHQ-4),
- 18 years old,
- able to understand, speak, and read English, and
- be able to provide informed consent.
- Exclusion Criteria
- diagnosed with borderline glaucoma or as a glaucoma suspect,
- had a glaucoma surgery in past month (e.g., trabeculectomy, glaucoma drainage device/tube),
- visual acuity of worse than 20/70 in the better seeing eye,
- diagnosed with a major medical conditions (e.g., cancer, or another visual disorder, like macular degeneration),
- diagnosed with a psychiatric conditions (e.g., schizophrenia, bipolar disorder), and
- reported or suspected cognitive impairment indicated by provider or chart review.
Exclusion
Key Trial Info
Start Date :
April 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 31 2026
Estimated Enrollment :
45 Patients enrolled
Trial Details
Trial ID
NCT06053307
Start Date
April 1 2025
End Date
March 31 2026
Last Update
June 5 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Duke University Eye Center
Durham, North Carolina, United States, 27705